Gabriel L Aguilar
Ophthalmology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · San Francisco Eye Institute Inc · 10 clinicians in this group
Hospitals listed: California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Gabriel L Aguilar’s office at (415) 421-8667 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G32877 · Current
Licensed to practise in California · since 1976 · expires 2028-04-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Eye Surgery Center of San FranciscoAmbulatory Surgery Center · San Francisco, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2013-11-13: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$205,631
Medicare paid this office $205,631 for 755 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 429 | $54,510 | $76 |
| Removal of cataract with insertion of prosthetic lens | 57 | $41,393 | $487 |
| Established patient complete exam of visual system | 398 | $38,834 | $97 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $13,835 | $659 |
| Removal of recurring cataract in lens capsule using a laser | 35 | $11,432 | $318 |
See all 12 services
| Established patient problem focused exam of visual system | 429 | $54,510 | $76 |
| Removal of cataract with insertion of prosthetic lens | 57 | $41,393 | $487 |
| Established patient complete exam of visual system | 398 | $38,834 | $97 |
| Complex removal of cataract with insertion of prosthetic lens | 20 | $13,835 | $659 |
| Removal of recurring cataract in lens capsule using a laser | 35 | $11,432 | $318 |
| New patient complete exam of visual system | 63 | $7,413 | $118 |
| Laser repair to improve eye fluid flow | 16 | $3,414 | $201 |
| Imaging of retina | 86 | $3,016 | $34 |
| Measurement of corneal curvature and depth of eye | 69 | $2,999 | $42 |
| New patient problem focused exam of visual system | 32 | $2,397 | $75 |
| Exam of visual field with extended testing | 43 | $2,350 | $53 |
| Imaging of optic nerve | 65 | $1,964 | $30 |
Procedures Medicare counted
| Cataract surgery | 187 | More than 83% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
755 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 22% · Women 55% · Also on Medicaid 14% · Health risk score 1.00. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 66% · Diabetes 21% · Coronary heart disease 20% · Cancer 17% · Chronic kidney disease 16% · Atrial fibrillation 15% · Depression 12% · Heart failure 10% · COPD 8% · Stroke 7% · Dementia 6%.
The office billed $559,294, Medicare allowed $286,616 and paid $205,631; for 2,396 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 755 | 2,396 | 79 | 1.00 | $559,294 | $205,631 |
| 2023 | 710 | 1,920 | 78 | 0.93 | $455,354 | $175,071 |
| 2022 | 716 | 1,857 | 78 | 0.92 | $447,192 | $128,147 |
| 2021 | 730 | 2,102 | 78 | 0.99 | $522,501 | $163,976 |
| 2020 | 721 | 1,962 | 78 | 1.08 | $455,511 | $131,609 |
| 2019 | 1,027 | 2,923 | 78 | 1.17 | $833,926 | $236,248 |
| 2018 | 1,136 | 3,015 | 78 | 1.08 | $897,981 | $245,737 |
| 2017 | 1,102 | 2,868 | 78 | 1.11 | $914,201 | $246,774 |
| 2016 | 1,209 | 3,308 | 78 | 1.12 | $1,011,559 | $286,132 |
| 2015 | 1,254 | 3,451 | 78 | 1.11 | $1,064,597 | $316,690 |
| 2014 | 1,275 | 3,883 | 78 | 1.09 | $1,005,006 | $308,423 |
| 2013 | 1,287 | 4,030 | 78 | 1.07 | $1,068,904 | $327,740 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Removal of cataract with insertion of prosthetic lens | 52 | $34,051 | $508 |
| Established patient complete exam of visual system | 262 | $30,976 | $117 |
| Established patient problem focused exam of visual system | 231 | $28,007 | $87 |
| Return visit (30+ min) | 195 | $16,976 | $87 |
| Short return visit | 193 | $10,236 | $40 |
| Complex removal of cataract with insertion of prosthetic lens | 12 | $9,004 | $693 |
| Removal of recurring cataract in lens capsule using a laser | 18 | $5,755 | $320 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $5,418 | $361 |
| Exam of visual field with extended testing | 61 | $3,270 | $53 |
| Short return visit (20+ min) | 33 | $2,553 | $71 |
| New patient complete exam of visual system | 18 | $2,128 | $118 |
| Removal of chronic growth of eyelid | 14 | $1,889 | $118 |
| Imaging of optic nerve | 52 | $1,819 | $34 |
| New patient visit (45+ min) | 11 | $1,667 | $152 |
| Ultrasound scan to determine eye length and lens power | 24 | $1,635 | $65 |
| Imaging of retina | 43 | $1,606 | $37 |
| Dilation of tear drainage opening | 15 | $1,582 | $93 |
| New patient visit (30+ min) | 17 | $1,328 | $78 |
| Measurement of corneal curvature and depth of eye | 23 | $1,157 | $46 |
2022: 12 services
| Return visit (30+ min) | 477 | $39,526 | $81 |
| Removal of cataract with insertion of prosthetic lens | 43 | $25,742 | $452 |
| Short return visit | 300 | $19,323 | $39 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $8,353 | $643 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $7,693 | $285 |
| New patient visit (30+ min) | 62 | $4,524 | $73 |
| Exam of visual field with extended testing | 63 | $3,306 | $51 |
| Ultrasound scan to determine eye length and lens power | 38 | $2,054 | $54 |
| Short return visit (20+ min) | 29 | $2,040 | $66 |
| New patient visit (45+ min) | 14 | $1,971 | $141 |
| Imaging of optic nerve | 42 | $1,206 | $29 |
| Imaging of retina | 17 | $540 | $32 |
2021: 13 services
| Return visit (30+ min) | 528 | $50,314 | $92 |
| Removal of cataract with insertion of prosthetic lens | 40 | $28,199 | $478 |
| Short return visit | 348 | $24,030 | $42 |
| Removal of recurring cataract in lens capsule using a laser | 45 | $14,607 | $311 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $12,581 | $662 |
| New patient visit (30+ min) | 61 | $5,305 | $87 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $4,169 | $278 |
| Exam of visual field with extended testing | 71 | $3,394 | $47 |
| Ultrasound scan to determine eye length and lens power | 44 | $2,584 | $59 |
| Short return visit (20+ min) | 26 | $1,569 | $60 |
| Imaging of optic nerve | 58 | $1,388 | $24 |
| Imaging of retina | 32 | $1,039 | $31 |
| Ultrasound scan of cornea to determine thickness | 21 | $197 | $9 |
2020: 14 services
| Return visit (30+ min) | 447 | $32,744 | $71 |
| Removal of cataract with insertion of prosthetic lens | 27 | $17,999 | $474 |
| Short return visit | 311 | $14,940 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 35 | $12,459 | $346 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $11,278 | $663 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $7,225 | $301 |
| New patient visit (30+ min) | 73 | $5,287 | $72 |
| Exam of visual field with extended testing | 55 | $2,585 | $45 |
| Imaging of optic nerve | 70 | $1,929 | $26 |
| Ultrasound scan to determine eye length and lens power | 39 | $1,788 | $45 |
| Imaging of retina | 55 | $1,783 | $31 |
| Short return visit (20+ min) | 30 | $1,628 | $54 |
| Dilation of tear drainage opening | 12 | $791 | $61 |
| Ultrasound scan of cornea to determine thickness | 11 | $117 | $10 |
2019: 15 services
| Removal of cataract with insertion of prosthetic lens | 77 | $67,252 | $565 |
| Return visit (30+ min) | 726 | $59,588 | $80 |
| Short return visit | 473 | $25,803 | $33 |
| Removal of recurring cataract in lens capsule using a laser | 81 | $25,432 | $292 |
| Complex removal of cataract with insertion of prosthetic lens | 15 | $13,889 | $694 |
| New patient visit (30+ min) | 114 | $8,496 | $75 |
| Exam of visual field with extended testing | 86 | $4,839 | $52 |
| Ultrasound scan to determine eye length and lens power | 81 | $4,433 | $55 |
| Imaging of optic nerve | 103 | $3,086 | $29 |
| Dilation of tear drainage opening | 17 | $1,635 | $78 |
| Imaging of retina | 48 | $1,618 | $32 |
| Removal of chronic growth of eyelid | 12 | $1,189 | $99 |
| Exam of the internal drainage system of eye | 45 | $1,076 | $23 |
| Short return visit (20+ min) | 13 | $926 | $66 |
| Ultrasound scan of cornea to determine thickness | 24 | $132 | $6 |
2018: 13 services
| Removal of cataract with insertion of prosthetic lens | 89 | $73,076 | $549 |
| Return visit (30+ min) | 795 | $60,272 | $74 |
| Short return visit | 541 | $30,099 | $31 |
| Removal of recurring cataract in lens capsule using a laser | 83 | $25,564 | $297 |
| Complex removal of cataract with insertion of prosthetic lens | 14 | $10,892 | $681 |
| New patient visit (30+ min) | 128 | $8,987 | $70 |
| Exam of visual field with extended testing | 114 | $5,780 | $49 |
| Ultrasound scan to determine eye length and lens power | 97 | $5,448 | $56 |
| Imaging of optic nerve | 109 | $3,173 | $29 |
| Imaging of retina | 51 | $1,609 | $32 |
| Short return visit (20+ min) | 14 | $734 | $52 |
| Dilation of tear drainage opening | 11 | $723 | $52 |
| Ultrasound scan of cornea to determine thickness | 20 | $198 | $10 |
2017: 12 services
| Removal of cataract with insertion of prosthetic lens | 103 | $79,801 | $547 |
| Return visit (30+ min) | 753 | $55,798 | $72 |
| Short return visit | 520 | $28,984 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 85 | $27,107 | $315 |
| New patient visit (30+ min) | 135 | $9,883 | $73 |
| Exam of visual field with extended testing | 121 | $6,371 | $52 |
| Ultrasound scan to determine eye length and lens power | 96 | $5,920 | $61 |
| Imaging of optic nerve | 116 | $3,267 | $27 |
| Imaging of retina | 57 | $2,086 | $31 |
| Ultrasound scan of cornea to determine thickness | 107 | $1,338 | $12 |
| Dilation of tear drainage opening | 13 | $1,125 | $70 |
| Short return visit (20+ min) | 15 | $758 | $51 |
2016: 10 services
| Removal of cataract with insertion of prosthetic lens | 120 | $96,073 | $562 |
| Return visit (30+ min) | 810 | $63,326 | $76 |
| Short return visit | 656 | $34,676 | $33 |
| Removal of recurring cataract in lens capsule using a laser | 106 | $32,299 | $302 |
| New patient visit (30+ min) | 150 | $10,873 | $72 |
| Ultrasound scan to determine eye length and lens power | 110 | $7,531 | $68 |
| Exam of visual field with extended testing | 121 | $6,645 | $54 |
| Imaging of optic nerve | 120 | $4,385 | $36 |
| Imaging of retina | 42 | $1,511 | $35 |
| Short return visit (20+ min) | 22 | $1,297 | $56 |
2015: 12 services
| Removal of cataract with insertion of prosthetic lens | 121 | $98,199 | $578 |
| Return visit (30+ min) | 845 | $68,753 | $79 |
| Short return visit | 672 | $39,489 | $34 |
| Removal of recurring cataract in lens capsule using a laser | 116 | $36,861 | $307 |
| New patient visit (30+ min) | 179 | $13,684 | $76 |
| Exam of visual field with extended testing | 151 | $9,079 | $57 |
| Ultrasound scan to determine eye length and lens power | 116 | $8,282 | $70 |
| Imaging of optic nerve | 100 | $3,642 | $36 |
| Imaging of retina | 73 | $3,032 | $40 |
| Removal of chronic growth of eyelid | 13 | $1,736 | $108 |
| Dilation of tear drainage opening | 14 | $1,411 | $94 |
| Short return visit (20+ min) | 22 | $1,201 | $55 |
2014: 10 services
| Removal of cataract with insertion of prosthetic lens | 113 | $94,236 | $600 |
| Return visit (30+ min) | 894 | $73,273 | $80 |
| Short return visit | 646 | $40,799 | $35 |
| Removal of recurring cataract in lens capsule using a laser | 80 | $26,718 | $311 |
| New patient visit (30+ min) | 163 | $12,397 | $76 |
| Exam of visual field with extended testing | 166 | $10,097 | $57 |
| Ultrasound scan to determine eye length and lens power | 106 | $7,531 | $71 |
| Imaging of optic nerve | 106 | $3,971 | $37 |
| Imaging of retina | 49 | $2,102 | $40 |
| Short return visit (20+ min) | 23 | $1,491 | $65 |
2013: 12 services
| Removal of cataract with insertion of prosthetic lens | 119 | $96,748 | $605 |
| Return visit (30+ min) | 861 | $71,145 | $81 |
| Short return visit | 641 | $40,782 | $35 |
| Removal of recurring cataract in lens capsule using a laser | 95 | $30,564 | $312 |
| New patient visit (30+ min) | 183 | $14,017 | $77 |
| Exam of visual field with extended testing | 164 | $9,731 | $56 |
| Ultrasound scan to determine eye length and lens power | 129 | $9,513 | $72 |
| Laser repair to improve eye fluid flow | 18 | $6,385 | $355 |
| Imaging of optic nerve | 120 | $4,803 | $38 |
| Imaging of retina | 80 | $3,695 | $42 |
| Short return visit (20+ min) | 31 | $1,433 | $46 |
| Ultrasound scan of cornea to determine thickness | 20 | $205 | $10 |
Medicaid work
$0 in 2018
Medicaid paid $0 for 27 billed services this clinician did in 2018, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DETERMINATION REFRACTIVE STATE | 14 | $0 |
| Return visit (30+ min) | 13 | $0 |
| 2018 | 27 | 2 | 14 | $0 |
Drugs they prescribed that Part D paid
$165,021
Pharmacies billed $165,021 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
778 generic and 703 brand-name prescriptions · $165,021 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyzulta | 107 | $44,576 | $417 |
| Lumigan | 47 | $30,661 | $652 |
| Rocklatan | 16 | $9,839 | $615 |
| Prednisolone Acetate | 146 | $6,800 | $47 |
| Brinzolamide | 20 | $5,010 | $251 |
See all 15 drugs
| Vyzulta | 107 | $44,576 | $417 |
| Lumigan | 47 | $30,661 | $652 |
| Rocklatan | 16 | $9,839 | $615 |
| Prednisolone Acetate | 146 | $6,800 | $47 |
| Brinzolamide | 20 | $5,010 | $251 |
| Ketorolac Tromethamine | 146 | $4,013 | $27 |
| Latanoprost | 281 | $3,579 | $13 |
| Xalatan | 12 | $3,119 | $260 |
| Ofloxacin | 144 | $2,225 | $15 |
| Dorzolamide-Timolol | 152 | $1,854 | $12 |
| Brimonidine | 33 | $1,181 | $36 |
| Methazolamide | 139 | $1,103 | $8 |
| Dorzolamide | 52 | $763 | $15 |
| Timolol Maleate | 32 | $257 | $8 |
| Neomycin-Polymyxin-Dexameth | 21 | $238 | $11 |
Year by year
| 2024 | 1,481 | 304 | None | 47% | $165,021 |
| 2023 | 1,338 | 286 | None | 46% | $179,391 |
| 2022 | 1,353 | 266 | None | None | $174,592 |
| 2021 | 1,331 | 261 | None | 49% | $186,184 |
| 2020 | 1,367 | 266 | None | 46% | $182,636 |
| 2019 | 1,856 | 343 | None | 41% | $183,051 |
| 2018 | 2,209 | 365 | None | 49% | $196,013 |
| 2017 | 2,313 | 378 | None | 47% | $203,593 |
| 2016 | 2,169 | 378 | None | 54% | $223,998 |
| 2015 | 2,405 | 389 | None | 61% | $229,284 |
| 2014 | 2,364 | 378 | None | 64% | $207,616 |
| 2013 | 2,276 | 368 | 0% (0) | 67% | $178,384 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Vyzulta | 74 | $36,880 | $498 |
| Lumigan | 51 | $31,022 | $608 |
| Rocklatan | 31 | $17,983 | $580 |
| Restasis | 15 | $11,043 | $736 |
| Latanoprost | 294 | $8,501 | $29 |
| Prednisolone Acetate | 113 | $6,210 | $55 |
| Simbrinza | 14 | $5,480 | $391 |
| Alphagan P | 11 | $4,132 | $376 |
| Brinzolamide | 13 | $4,103 | $316 |
| Dorzolamide-Timolol | 126 | $3,705 | $29 |
| Ketorolac Tromethamine | 119 | $3,549 | $30 |
| Brimonidine | 24 | $3,466 | $144 |
| Brimonidine Tartrate-Timolol | 12 | $3,003 | $250 |
| Ofloxacin | 96 | $2,390 | $25 |
| Dorzolamide | 56 | $1,862 | $33 |
| Methazolamide | 81 | $1,359 | $17 |
| Timolol Maleate | 59 | $705 | $12 |
| Moxifloxacin | 11 | $370 | $34 |
| Neomycin-Polymyxin-Dexameth | 19 | $269 | $14 |
2022: 19 drugs
| Lumigan | 70 | $40,355 | $577 |
| Rocklatan | 40 | $23,365 | $584 |
| Latanoprost | 363 | $11,008 | $30 |
| Simbrinza | 26 | $8,053 | $310 |
| Azopt | 20 | $7,897 | $395 |
| Alphagan P | 13 | $6,325 | $487 |
| Combigan | 13 | $5,495 | $423 |
| Brimonidine | 24 | $5,184 | $216 |
| Dorzolamide-Timolol | 143 | $4,972 | $35 |
| Travoprost | 11 | $4,581 | $416 |
| Prednisolone Acetate | 96 | $4,231 | $44 |
| Ketorolac Tromethamine | 108 | $2,413 | $22 |
| Dorzolamide | 63 | $2,232 | $35 |
| Ofloxacin | 124 | $2,011 | $16 |
| Tobramycin-Dexamethasone | 18 | $1,385 | $77 |
| Methazolamide | 44 | $1,161 | $26 |
| Timolol Maleate | 36 | $1,092 | $30 |
| Olopatadine | 12 | $359 | $30 |
| Neomycin-Polymyxin-Dexameth | 15 | $167 | $11 |
2021: 17 drugs
| Lumigan | 63 | $40,756 | $647 |
| Rocklatan | 58 | $39,853 | $687 |
| Azopt | 38 | $16,443 | $433 |
| Latanoprost | 319 | $10,505 | $33 |
| Travoprost | 16 | $7,060 | $441 |
| Simbrinza | 20 | $6,937 | $347 |
| Alphagan P | 16 | $6,906 | $432 |
| Brimonidine | 27 | $6,202 | $230 |
| Combigan | 15 | $5,985 | $399 |
| Dorzolamide-Timolol | 168 | $5,655 | $34 |
| Prednisolone Acetate | 101 | $3,454 | $34 |
| Ketorolac Tromethamine | 109 | $2,596 | $24 |
| Dorzolamide | 66 | $2,193 | $33 |
| Ofloxacin | 108 | $1,574 | $15 |
| Timolol Maleate | 38 | $692 | $18 |
| Methazolamide | 57 | $456 | $8 |
| Neomycin-Polymyxin-Dexameth | 13 | $234 | $18 |
2020: 18 drugs
| Lumigan | 90 | $50,660 | $563 |
| Azopt | 58 | $26,633 | $459 |
| Latanoprost | 368 | $11,751 | $32 |
| Combigan | 29 | $10,748 | $371 |
| Dorzolamide-Timolol | 160 | $8,799 | $55 |
| Travoprost | 13 | $5,000 | $385 |
| Simbrinza | 17 | $4,464 | $263 |
| Alphagan P | 14 | $4,440 | $317 |
| Brimonidine | 29 | $3,556 | $123 |
| Prednisolone Acetate | 86 | $3,010 | $35 |
| Dorzolamide | 75 | $2,932 | $39 |
| Ketorolac Tromethamine | 100 | $2,284 | $23 |
| Olopatadine | 26 | $1,321 | $51 |
| Tobramycin-Dexamethasone | 14 | $1,161 | $83 |
| Ofloxacin | 80 | $1,094 | $14 |
| Methazolamide | 41 | $1,056 | $26 |
| Timolol Maleate | 56 | $843 | $15 |
| Neomycin-Polymyxin-Dexameth | 11 | $170 | $15 |
2019: 22 drugs
| Lumigan | 90 | $41,285 | $459 |
| Azopt | 49 | $20,880 | $426 |
| Travatan Z | 42 | $18,285 | $435 |
| Latanoprost | 486 | $12,935 | $27 |
| Combigan | 30 | $10,885 | $363 |
| Dorzolamide-Timolol | 166 | $10,308 | $62 |
| Prednisolone Acetate | 169 | $6,263 | $37 |
| Pazeo | 11 | $4,744 | $431 |
| Ilevro | 13 | $3,979 | $306 |
| Durezol | 19 | $3,655 | $192 |
| Alphagan P | 13 | $3,584 | $276 |
| Ketorolac Tromethamine | 171 | $3,323 | $19 |
| Simbrinza | 14 | $2,829 | $202 |
| Ofloxacin | 168 | $2,615 | $16 |
| Dorzolamide | 69 | $2,442 | $35 |
| Tobramycin-Dexamethasone | 25 | $2,252 | $90 |
| Besivance | 12 | $2,249 | $187 |
| Brimonidine | 23 | $1,752 | $76 |
| Olopatadine | 25 | $1,688 | $68 |
| Methazolamide | 98 | $1,560 | $16 |
| Timolol Maleate | 64 | $1,092 | $17 |
| Neomycin-Polymyxin-Dexameth | 17 | $323 | $19 |
2018: 24 drugs
| Lumigan | 114 | $42,429 | $372 |
| Azopt | 50 | $20,480 | $410 |
| Travatan Z | 46 | $18,027 | $392 |
| Combigan | 58 | $13,960 | $241 |
| Latanoprost | 657 | $13,603 | $21 |
| Ilevro | 21 | $6,836 | $326 |
| Prednisolone Acetate | 176 | $6,698 | $38 |
| Durezol | 33 | $5,837 | $177 |
| Alphagan P | 19 | $5,623 | $296 |
| Pazeo | 17 | $4,318 | $254 |
| Dorzolamide-Timolol | 132 | $4,145 | $31 |
| Simbrinza | 15 | $3,488 | $233 |
| Ketorolac Tromethamine | 173 | $3,340 | $19 |
| Besivance | 18 | $2,971 | $165 |
| Pataday | 14 | $2,429 | $173 |
| Brimonidine | 26 | $2,286 | $88 |
| Ofloxacin | 156 | $2,189 | $14 |
| Tobramycin-Dexamethasone | 26 | $2,053 | $79 |
| Olopatadine | 23 | $2,053 | $89 |
| Dorzolamide | 61 | $1,815 | $30 |
| Timolol Maleate | 118 | $1,562 | $13 |
| Methazolamide | 111 | $762 | $7 |
| Acyclovir | 11 | $572 | $52 |
| Neomycin-Polymyxin-Dexameth | 28 | $478 | $17 |
2017: 24 drugs
| Lumigan | 131 | $41,297 | $315 |
| Azopt | 64 | $23,171 | $362 |
| Ilevro | 89 | $22,299 | $251 |
| Travatan Z | 53 | $20,023 | $378 |
| Durezol | 85 | $13,734 | $162 |
| Latanoprost | 685 | $12,246 | $18 |
| Restasis | 16 | $10,151 | $634 |
| Dorzolamide-Timolol | 222 | $6,737 | $30 |
| Combigan | 40 | $6,493 | $162 |
| Pataday | 24 | $6,050 | $252 |
| Alphagan P | 21 | $5,267 | $251 |
| Prednisolone Acetate | 113 | $4,133 | $37 |
| Zioptan | 13 | $3,263 | $251 |
| Simbrinza | 18 | $3,077 | $171 |
| Ofloxacin | 177 | $2,863 | $16 |
| Ketorolac Tromethamine | 132 | $1,987 | $15 |
| Xalatan | 11 | $1,983 | $180 |
| Pazeo | 11 | $1,830 | $166 |
| Dorzolamide | 55 | $1,521 | $28 |
| Tobramycin-Dexamethasone | 15 | $1,244 | $83 |
| Timolol Maleate | 88 | $864 | $10 |
| Acyclovir | 11 | $804 | $73 |
| Methazolamide | 118 | $765 | $6 |
| Neomycin-Polymyxin-Dexameth | 19 | $273 | $14 |
2016: 23 drugs
| Ilevro | 151 | $36,812 | $244 |
| Lumigan | 125 | $30,527 | $244 |
| Azopt | 73 | $24,801 | $340 |
| Travatan Z | 77 | $24,507 | $318 |
| Durezol | 138 | $21,405 | $155 |
| Restasis | 31 | $16,506 | $532 |
| Latanoprost | 657 | $11,390 | $17 |
| Pataday | 28 | $8,109 | $290 |
| Alphagan P | 23 | $6,038 | $263 |
| Simbrinza | 37 | $5,344 | $144 |
| Combigan | 24 | $5,286 | $220 |
| Dorzolamide-Timolol | 151 | $3,809 | $25 |
| Ofloxacin | 158 | $2,716 | $17 |
| Methazolamide | 131 | $2,520 | $19 |
| Prednisolone Acetate | 40 | $1,813 | $45 |
| Ketorolac Tromethamine | 66 | $1,705 | $26 |
| Dorzolamide | 53 | $1,411 | $27 |
| Brimonidine | 12 | $1,247 | $104 |
| Pilocarpine | 13 | $1,188 | $91 |
| Acyclovir | 12 | $898 | $75 |
| Tobramycin-Dexamethasone | 12 | $818 | $68 |
| Neomycin-Polymyxin-Dexameth | 13 | $415 | $32 |
| Timolol Maleate | 33 | $378 | $11 |
2015: 25 drugs
| Azopt | 125 | $32,356 | $259 |
| Lumigan | 164 | $31,054 | $189 |
| Ilevro | 122 | $29,146 | $239 |
| Durezol | 132 | $20,032 | $152 |
| Travatan Z | 91 | $19,039 | $209 |
| Restasis | 28 | $13,956 | $498 |
| Pataday | 40 | $10,335 | $258 |
| Latanoprost | 682 | $9,665 | $14 |
| Alphagan P | 43 | $8,454 | $197 |
| Nevanac | 36 | $7,327 | $204 |
| Simbrinza | 41 | $5,817 | $142 |
| Combigan | 26 | $4,166 | $160 |
| Dorzolamide-Timolol | 158 | $3,810 | $24 |
| Ofloxacin | 193 | $2,938 | $15 |
| Prolensa | 13 | $2,773 | $213 |
| Prednisolone Acetate | 53 | $2,481 | $47 |
| Methazolamide | 134 | $2,411 | $18 |
| Tobramycin-Dexamethasone | 23 | $1,900 | $83 |
| Ketorolac Tromethamine | 61 | $1,559 | $26 |
| Xalatan | 11 | $1,441 | $131 |
| Brimonidine | 25 | $1,366 | $55 |
| Dorzolamide | 44 | $1,169 | $27 |
| Fluorometholone | 14 | $1,092 | $78 |
| Neomycin-Polymyxin-Dexameth | 22 | $320 | $15 |
| Timolol Maleate | 29 | $199 | $7 |
2014: 26 drugs
| Azopt | 188 | $34,886 | $186 |
| Lumigan | 196 | $33,373 | $170 |
| Nevanac | 140 | $24,220 | $173 |
| Travatan Z | 88 | $16,286 | $185 |
| Durezol | 121 | $15,542 | $128 |
| Restasis | 25 | $12,951 | $518 |
| Latanoprost | 653 | $12,080 | $18 |
| Pataday | 34 | $7,626 | $224 |
| Combigan | 30 | $5,913 | $197 |
| Dorzolamide-Timolol | 180 | $5,363 | $30 |
| Alphagan P | 41 | $5,008 | $122 |
| Alrex | 14 | $3,161 | $226 |
| Patanol | 13 | $2,572 | $198 |
| Simbrinza | 23 | $2,319 | $101 |
| Brimonidine | 42 | $1,946 | $46 |
| Ofloxacin | 166 | $1,834 | $11 |
| Prednisolone Acetate | 35 | $1,792 | $51 |
| Xalatan | 11 | $1,357 | $123 |
| Ketorolac Tromethamine | 55 | $1,322 | $24 |
| Tobramycin-Dexamethasone | 11 | $1,016 | $92 |
| Dorzolamide | 21 | $952 | $45 |
| Fluorometholone | 16 | $784 | $49 |
| Pilocarpine | 11 | $757 | $69 |
| Methazolamide | 129 | $602 | $5 |
| Neomycin-Polymyxin-Dexameth | 22 | $379 | $17 |
| Timolol Maleate | 11 | $72 | $7 |
2013: 23 drugs
| Lumigan | 189 | $30,843 | $163 |
| Azopt | 185 | $28,815 | $156 |
| Nevanac | 132 | $19,548 | $148 |
| Travatan Z | 115 | $18,284 | $159 |
| Latanoprost | 669 | $13,255 | $20 |
| Durezol | 111 | $12,261 | $110 |
| Restasis | 33 | $12,118 | $367 |
| Alphagan P | 60 | $6,181 | $103 |
| Dorzolamide-Timolol | 146 | $5,755 | $39 |
| Pataday | 19 | $4,216 | $222 |
| Combigan | 40 | $4,106 | $103 |
| Alrex | 17 | $2,745 | $161 |
| Xalatan | 18 | $2,039 | $113 |
| Brimonidine | 44 | $1,602 | $36 |
| Erythromycin | 12 | $1,348 | $112 |
| Ofloxacin | 142 | $1,190 | $8 |
| Dorzolamide | 15 | $696 | $46 |
| Pilocarpine | 18 | $690 | $38 |
| Prednisolone Acetate | 28 | $609 | $22 |
| Ketorolac Tromethamine | 28 | $602 | $21 |
| Neomycin-Polymyxin-Dexameth | 27 | $489 | $18 |
| Methazolamide | 106 | $435 | $4 |
| Fluorometholone | 19 | $159 | $8 |
Money from drug and device companies
$233 in 2025
| 2025 | 6 | 9 | None | $233 |
| 2024 | 10 | 15 | None | $361 |
| 2023 | 7 | 16 | None | $425 |
| 2022 | 3 | 5 | None | $122 |
| 2021 | 4 | 7 | None | $157 |
| 2020 | 5 | 6 | None | $126 |
| 2019 | 5 | 9 | None | $173 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Tryptyr | $89 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $47 | 2 payments
|
| Dompe US | Oxervate | $33 | 1 payment
|
| Abbvie | Lumigan | $24 | 1 payment
|
| Glaukos | Photrexa Viscous and Photrexa | $22 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $20 | 1 payment
|
See all 9 published payments
| Oyster Point Pharma | Meals · 2025-11-05 | Tyrvaya | $26 |
| Oyster Point Pharma | Meals · 2025-09-26 | Tyrvaya | $21 |
| Glaukos | Meals · 2025-09-11 | Photrexa Viscous and Photrexa | $22 |
| Abbvie | Meals · 2025-09-04 | Lumigan | $24 |
| Bausch & Lomb Americas | Meals · 2025-08-28 | Vyzulta | $20 |
| Alcon Vision | Meals · 2025-08-14 | Tryptyr | $33 |
| Alcon Vision | Meals · 2025-05-28 | Rocklatan | $33 |
| Alcon Vision | Meals · 2025-05-01 | Hydrus Microstent | $22 |
| Dompe US | Meals · 2025-01-29 | Oxervate | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $361
| Abbott Laboratories | Alinity | $68 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $66 | 2 payments
|
| Abbvie | Lumigan | $52 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $45 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $26 | 1 payment
|
| RxSight | Rxsight Contact Lens | $25 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $22 | 1 payment
|
| Amgen | Tepezza | $21 | 1 payment
|
| Alcon Vision | Clareon | $20 | 1 payment
|
| Dompe US | Oxervate | $16 | 1 payment
|
2023: $425
| AbbVie | Durysta | $168 | 5 payments
|
| Oyster Point Pharma | Tyrvaya | $78 | 3 payments
|
| Alcon Vision | Clareon | $72 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $47 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $24 | 1 payment
|
| Thea Pharma | Iyuzeh | $18 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $17 | 1 payment
|
2022: $122
| Abbvie | Vuity | $53 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $44 | 2 payments
|
| Bausch & Lomb Americas | Vyzulta | $25 | 1 payment
|
2021: $157
| Aerie Pharmaceuticals | Rhopressa | $88 | 4 payments
|
| EyePoint Pharmaceuticals US | Yutiq | $25 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $22 | 1 payment
|
| Allergan | Lumigan | $21 | 1 payment
|
2020: $126
| Aerie Pharmaceuticals | Rocklatan | $48 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $21 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $21 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $20 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $15 | 1 payment
|
2019: $173
| Bausch & Lomb a division of Bausch Health US | Prolensa | $70 | 3 payments
|
| Allergan | Lumigan | $42 | 2 payments
|
| Sun Pharmaceutical Industries | Xelpros | $33 | 2 payments
|
| Alcon Vision | Ilux | $16 | 1 payment
|
| Omeros | Omidria | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366544371
- Licence
- CA G32877California G32877: Current · expires 2028-04-30
- Trained
- University of California, Geffen School of Medicine, 1974
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 909 Hyde Street, Suite 530, San Francisco, CA, 94109
- NPI first listed
- 2006-09-01
- NPI last updated
- 2007-07-09
This is when the NPI record was last certified, not a medical board exam.